|| Worldwide, breast cancer accounts for 22.9% of all cancers excluding non-melanoma skin cancers in women. More than 80% of breast cancer cases are discovered when a woman discovers a lump that feels different from the rest of the breast tissue. We report the case of a 60-year-old woman who had been treated for one year at a psychiatric hospital for suspected schizophrenia, and was referred to our hospital on March 23, 2011 for consultation regarding complete blood count abnormalities: hemoglobin, 4.8g/㎗ ; Plt, 1.9×104/μl ; WBC, 12,700/μl with 18.5% abnormal cells. Computed tomography revealed an enhanced, irregular mass in her right breast as well as right axillary lymph node swelling, suggestive of breast cancer. BM biopsy confirmed the presence of abnormal, keratin-positive cells, suggesting metastasis to the bone. CA15-3 was 300U/㎖ (normal range ＜25). The patient died on April 11, 2011, post-admission day 20. We found a rare case of terminal breast cancer that presented with peripheral blood abnormality. Breast cancer in patients who do not notice breast abnormality can present with peripheral blood abnormality.
|| 1) Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS : Effects of multidisciplinary team working on breast cancer survival : retrospective, comparative, interventional cohort study of 13 722 women. BMJ (2012) 344, e2718.
2) Bastiaannet E, Liefers GJ, de Craen AJ, Kuppen PJ, van de Water W, Portielje JE, van der Geest LG, Janssen-Heijnen ML, Dekkers OM, van de Velde CJ, Westendorp RG : Breast cancer in elderly compared to younger patients in the Netherlands : stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat (2010) 124, 801-807.
3) Newman LA : Epidemiology of locally advanced breast cancer. Semin Radiat Oncol (2009) 19, 195-203.
4) Lacroix M : Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer (2006) 13, 1033-1067.
5) Braun S, Naume B : Circulating and disseminated tumor cells. J Clin Oncol (2005) 23, 1623-1626.
6) Abdulkareem IH, Zurmi IB : Review of hormonal treatment of breast cancer. Niger J Clin Pract (2012) 15, 9-14.
7) Abramson V, Arteaga CL : New strategies in HER2-overexpressing breast cancer : many combinations of targeted drugs available. Clin Cancer Res (2011) 17, 952-958.
8) Bushe CJ, Bradley AJ, Wildgust HJ, Hodgson RE : Schizophrenia and breast cancer incidence : a systematic review of clinical studies. Schizophr Res (2009) 114, 6-16.
9) Maguire GA : Prolactin elevation with antipsychotic medications : mechanisms of action and clinical consequences. J Clin Psychiatry (2002) 63, 56-62.